Bringing cervical cancer screening to women with HIV: can Home-Delivered HPV tests make a difference?

NCT ID NCT07428330

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways to offer cervical cancer screening to women living with HIV: standard clinic-based screening versus adding community outreach where health workers provide HPV self-collection kits at home or in community settings. About 7,600 women across multiple clinics will take part. The goal is to see if the community approach increases how many women get screened.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
HPV self-collection kit
What this could lead to
If successful, this could show that community-based HPV self-collection is a practical way to increase cervical cancer screening rates among women living with HIV.
What could go wrong
This is an implementation study, not a test of a new treatment. It may not prove that screening reduces cancer rates, and results may vary by location.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVIX CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Makerere University Walter Reed Program

    RECRUITING

    Kampala, 16524, Uganda

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.